Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Crossover Trial to Characterize the Performance of the Spectra Optia Apheresis System Versus the COBE Spectra Apheresis System for Collection of Mononuclear Cells in Healthy Adult Donors

NCT02253160 is registered in ClinicalTrials.gov with Terumo BCT as lead sponsor.

NCT NCT02253160
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02253160 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Crossover Trial to Characterize the Performance of the Spectra Optia Apheresis System Versus the COBE Spectra Apheresis System for Collection of Mononuclear Cells in Healthy Adult Donors
Lead sponsor
Terumo BCT
Phase
Not applicable
Overall status
Completed
Start date
September 30, 2014
Completion date
January 31, 2015
Enrollment
23 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

healthy apheresis donors, mononuclear (mnc) cell donors